RxDoctor Payments Data

Sandra Rebish, MD

Dermatology · Upland, CANPI 1235252289

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $639,270 of the $746,364 with a category attached, or 85.7%. 14 manufacturers reported payments, led by Incyte Corporation at 57.6% of the total. Reporting peaked in 2024 at $564,594 and has fallen 80.2% since, to $111,724 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$746,364in general payments, 2019–2025

Across 100 payments — averaging $7463.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$430K
  • UCB, Inc.$241K
  • Sun Pharmaceutical Industries Inc.$67K
  • Janssen Scientific Affairs, LLC$4K
  • AbbVie$2K
  • Novartis$597
  • plus $1K from 8 others

What the payments were for

  • Consulting fees$639,27086%
  • Speaking & faculty fees$64,0009%
  • Travel & lodging$40,0825%
  • Food & beverage$3,0120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation32$430,182
UCB, Inc.6$240,590
Sun Pharmaceutical Industries Inc.7$67,079
Janssen Scientific Affairs, LLC1$4,250
AbbVie(2 entities)10$2,333
Novartis18$597
Galderma Laboratories, L.p.4$461
Johnson & Johnson3$257
Merz North America, Inc.5$228
Sanofi3$164
Abbott7$152
Amgen2$35
Sensus Healthcare, Inc.1$21
DUSA Pharmaceuticals, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$746,364 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California

Medicare billing

Part B allowed, 2024
$57,920
Medicare patients
113
Services billed
308

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other dermatology in Upland

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →